Bedaquiline (BDQ) resistance in an adolescent with multidrug-resistant tuberculosis (MDR-TB): An alarm for pediatricians

Bedaquiline (BDQ) use for all age groups in drug-resistant (DR) tuberculosis (TB) regimens for children may be shorter, safer, and more effective. However, the emergence of BDQ resistance reports soon after its introduction is alarming. We report the case of a 17-year-old boy, initially diagnosed wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesilia, Citra, Tirtosudiro, Muh Akbar, Nataprawira, Heda Melinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509653/
https://www.ncbi.nlm.nih.gov/pubmed/37736021
http://dx.doi.org/10.1016/j.idcr.2023.e01880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509653/
https://www.ncbi.nlm.nih.gov/pubmed/37736021
http://dx.doi.org/10.1016/j.idcr.2023.e01880

Ejemplares similares